» Authors » Zanariah Hussein

Zanariah Hussein

Explore the profile of Zanariah Hussein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 422
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hassanein M, Zainudin S, Shaikh S, Shaltout I, Malek R, Buyukbese M, et al.
Curr Med Res Opin . 2024 Jul; 40(9):1515-1523. PMID: 39076065
Background: Managing diabetes during Ramadan fasting is a challenge due lifestyle changes. We described the characteristics and patterns of care for type 2 diabetes mellitus (T2DM) during Ramadan 2020 and...
2.
Wan Puteh S, Kamarudin N, Hussein Z, Adam N, Shahari M
BMC Public Health . 2024 Jul; 24(1):2003. PMID: 39061035
Background: Cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) are non-communicable diseases that impose a significant economic burden on healthcare systems, particularly in low- and middle-income countries. The purpose...
3.
Lim L, Hussein Z, Noor N, Raof A, Mustafa N, Bidin M, et al.
PLoS One . 2024 Jan; 19(1):e0296298. PMID: 38166049
Aim: Given a lack of data on diabetes care performance in Malaysia, we conducted a cross-sectional study to understand the clinical characteristics, control of cardiometabolic risk factors, and patterns of...
4.
Sim R, Chong C, Loganadan N, Hussein Z, Adam N, Lee S
Patient Prefer Adherence . 2023 Aug; 17:2109-2117. PMID: 37644964
Medication adherence profoundly affects blood glucose management in patients with type 2 diabetes. Measures to contain the COVID-19 pandemic have affected disease management and medication adherence, owing to limited access...
5.
Sim R, Chong C, Loganadan N, Saidoung P, Adam N, Hussein Z, et al.
Value Health Reg Issues . 2023 Jul; 38:9-17. PMID: 37419012
Objectives: This study aims to evaluate the cost-effectiveness of various glucose-lowering therapies as add-on to standard care for people with type 2 diabetes (T2D) in Malaysia. Methods: A state-transition microsimulation...
6.
Hassanein M, Yousuf S, Ahmedani M, Albashier A, Shaltout I, Yong A, et al.
Diabetes Metab Syndr . 2023 Jun; 17(7):102799. PMID: 37301008
Background And Aims: The DaR Global survey was conducted to observe the impact of the COVID-19 pandemic on the intentions to fast and the outcomes of fasting in people with...
7.
Mohamed M, Lim S, Mumtaz M, Uppal S, Mukherjee D, Kassim M, et al.
J ASEAN Fed Endocr Soc . 2023 May; 38(1):37-44. PMID: 37252419
Objectives: Insulin degludec (IDeg)/insulin aspart (IAsp; IDegAsp) is a co-formulation of 70% IDeg and 30% IAsp. According to several randomized controlled trials, IDegAsp is effective and safe for patients with...
8.
Bidin M, Khan A, Tan F, Aziz N, Ali N, Kamaruddin N, et al.
J ASEAN Fed Endocr Soc . 2023 May; 38(1):75-80. PMID: 37252416
Objective: This study aims to report the demographic features of patients with acromegaly, the disease burden, and the corresponding treatment patterns and outcomes in Malaysia. Methodology: This is a retrospective...
9.
Sim R, Chong C, Loganadan N, Adam N, Hussein Z, Lee S
Clin Kidney J . 2023 Mar; 16(3):549-559. PMID: 36865020
Background: Diabetes is one of the leading causes of chronic kidney disease (CKD) and end-stage renal disease. This study aims to develop and validate different risk predictive models for incident...
10.
Wong P, Lim S, Tong C, Mohamad M, Hussein Z
J ASEAN Fed Endocr Soc . 2022 Dec; 37(2):106-112. PMID: 36578894
Thyroid hormone plays an important role in cardiovascular function. Pericardial effusions are commonly seen in cases of severe hypothyroidism. However, large to massive pericardial effusions with cardiac tamponade are exceptionally...